Renaissance Technologies
NVAX icon

Renaissance Technologies’s Novavax NVAX Stock Holding History

Renaissance Technologies’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05M Buy
+497,383
New +$4.51M 0.01% 1490
2025
Q4 		– Sell
-1,196,750
Closed -$10.4M – 3592
2025
Q3 		$10.4M Buy
1,196,750
+529,103
+79% +$4.12M 0.01% 1082
2025
Q2 		$4.21M Buy
667,647
+162,400
+32% +$1.08M 0.01% 1637
2025
Q1 		$3.24M Sell
505,247
-902,283
-64% -$7.46M ﹤0.01% 1703
2024
Q4 		$11.3M Sell
1,407,530
-657,253
-32% -$6.34M 0.02% 945
2024
Q3 		$26.1M Buy
2,064,783
+954,600
+86% +$12.3M 0.04% 549
2024
Q2 		$14.1M Buy
+1,110,183
New +$11.2M 0.02% 754
2023
Q3 		– Sell
-438,883
Closed -$3.26M – 3958
2023
Q2 		$3.26M Sell
438,883
-3,101,500
-88% -$24.4M ﹤0.01% 1677
2023
Q1 		$24.5M Buy
3,540,383
+718,700
+25% +$6.61M 0.03% 616
2022
Q4 		$29M Buy
2,821,683
+1,941,100
+220% +$34.3M 0.04% 547
2022
Q3 		$16M Buy
+880,583
New +$38.2M 0.02% 786
2021
Q2 		– Sell
-672,683
Closed -$122M – 3683
2021
Q1 		$122M Buy
+672,683
New +$134M 0.15% 134
2020
Q4 		– Sell
-208,583
Closed -$22.6M – 3622
2020
Q3 		$22.6M Buy
+208,583
New +$25.4M 0.02% 684
2019
Q2 		– Sell
-120,883
Closed -$1.33M – 3701
2019
Q1 		$1.33M Buy
120,883
+99,685
+470% +$3.15M ﹤0.01% 2538
2018
Q4 		$780K Buy
+21,198
New +$822K ﹤0.01% 2692
2018
Q2 		– Sell
-289,323
Closed -$12.2M – 3449
2018
Q1 		$12.2M Buy
289,323
+148,545
+106% +$5.97M 0.01% 1243
2017
Q4 		$3.49M Buy
140,778
+5,280
+4% +$129K ﹤0.01% 2032
2017
Q3 		$3.09M Buy
135,498
+73,190
+117% +$1.64M ﹤0.01% 2060
2017
Q2 		$1.43M Buy
62,308
+46,865
+303% +$920K ﹤0.01% 2429
2017
Q1 		$395K Sell
15,443
-6,128
-28% -$169K ﹤0.01% 2839
2016
Q4 		$544K Buy
+21,571
New +$629K ﹤0.01% 2737
2015
Q4 		– Sell
-91,570
Closed -$12.9M – 3378
2015
Q3 		$12.9M Buy
91,570
+37,292
+69% +$8.36M 0.03% 759
2015
Q2 		$12.1M Buy
+54,278
New +$9.54M 0.03% 830

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's NVAX Position: Q1 2026 in Review

Renaissance Technologies opened a new position in Novavax (NVAX) in Q1 2026: 497,383 shares worth $4.05M. The stake represents 0.01% of the portfolio and ranks #1490 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in NVAX as recently as Q3 2025.

Renaissance Technologies first reported a position in NVAX in Q2 2015 and has held it in 23 quarters since. The position peaked at $122M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Renaissance Technologies held 497,383 shares of Novavax worth $4.05M as of Q1 2026.
  • Novavax was a new Renaissance Technologies position in Q1 2026.
  • Novavax made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1490 holding.
  • Renaissance Technologies first reported a position in Novavax in Q2 2015 and has held it in 23 quarters since.
  • Renaissance Technologies's Novavax position peaked at $122M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.